LOTUS PHARMACEUTICALS, INC.
CIK 0001292087
Revenue (TTM)
$74.95M
Q3 Nov 2011
Net Income (TTM)
$16.05M
Q3 Nov 2011
EPS Diluted (TTM)
$0.59
Q3 Nov 2011
Gross Margin
37.9%
Q3 Nov 2011
Operating Margin
21.6%
Q3 Nov 2011
Net Margin
21.4%
Q3 Nov 2011
Free Cash Flow (TTM)
—
Q3 Nov 2011
Cash
$158.91K
Q3 Nov 2011
Total Debt
—
Q3 Nov 2011
Shares Outstanding
27.82M sh
Q3 Nov 2011